Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast Cancer
- Sponsor
- European Organisation for Research and Treatment of Cancer - EORTC
- Study ID
- NCT00049660
- Phase
- PHASE2/PHASE3
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- capecitabine — DRUG
- vinorelbine tartrate — DRUG
Study Details
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if capecitabine is more effective than vinorelbine in treating metastatic breast cancer. PURPOSE: Randomized phase II/III trial to compare the effectiveness of capecitabine with that of vinorelbine in treating women who have metastatic breast cancer that has been previously treated with chemotherapy.
Key Dates
- Start date
- Sep 30, 2002
- Status verified
- Jul 2012
- Primary completion
- Dec 31, 2004
Study Design
- Enrollment
- 47 participants (actual)
- Allocation
- RANDOMIZED
- Primary purpose
- TREATMENT
Related Studies
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Harvesting Cells for Experimental Cancer TreatmentsEnrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
- High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast CancerRecruiting · Carol Fabian, MD · Kansas City, Kansas
- Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland